NASDAQ

Jasper Therapeutics, Inc. - Class A (JSPR)

♥ 708 Thanks from members

Live price chart, market sentiment, and community perspectives for Jasper Therapeutics, Inc. - Class A (NASDAQ: JSPR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Judi K. WoolgerFounder: Etienne BuchetLeadership: William Ho (CEO)Leadership: Kamilia Lin (CFO)Holder: OrbiMed AdvisorsHolder: Cowen Healthcare InvestmentsHolder: Point72 Asset ManagementJSP191 (Emapalumab equivalent/CD115)Gene Therapy Conditioning Agents#JSPR#Jasper Therapeutics#Biotech Stock#Immunology#JSP191